NDC product
Prempro
NDC 0046-1105 · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Key facts
| Product NDC | 0046-1105 |
|---|---|
| Proprietary name | Prempro |
| Nonproprietary name | conjugated estrogens and medroxyprogesterone acetate |
| Substances | ESTROGENS, CONJUGATED, MEDROXYPROGESTERONE ACETATE |
| Dosage form | TABLET, SUGAR COATED |
| Route | ORAL |
| Labeler | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA020527 |
| Pharmacologic classes | Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS], Progesterone Congeners [CS], Progestin [EPC] |
| Marketing start | Sep 21, 2009 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: